医院获得性菌血症和真菌血症的可预防性：一种潜在的医疗保健相关性感染结局测量方法的初步研究。
Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.
机构信息
Division of Hospital Medicine, Department of Medicine,Emory University School of Medicine,Atlanta, Georgia.
Division of Infectious Diseases, Department of Medicine,Johns Hopkins University School of Medicine,Baltimore, Maryland.
出版信息
Infect Control Hosp Epidemiol. 2019 Mar;40(3):358-361. doi: 10.1017/ice.2018.339. Epub 2019 Feb 18.
Abstract
Hospital-onset bacteremia and fungemia (HOB), a potential measure of healthcare-associated infections, was evaluated in a pilot study among 60 patients across 3 hospitals. Two-thirds of all HOB events and half of nonskin commensal HOB events were judged as potentially preventable. Follow-up studies are needed to further develop this measure.
摘要
医院获得性菌血症和真菌血症（HOB），是一种潜在的医疗保健相关感染的衡量指标，在 3 家医院的 60 名患者中进行了试点研究。所有 HOB 事件的三分之二和非皮肤共生 HOB 事件的一半被认为是可以预防的。需要进一步开展随访研究来进一步完善这一措施。
相似文献
1
Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.医院获得性菌血症和真菌血症的可预防性：一种潜在的医疗保健相关性感染结局测量方法的初步研究。
Infect Control Hosp Epidemiol. 2019 Mar;40(3):358-361. doi: 10.1017/ice.2018.339. Epub 2019 Feb 18.
2
Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.印度 2 家医院的医院获得性菌血症和真菌血症的流行病学和可预防措施。
Infect Control Hosp Epidemiol. 2024 Feb;45(2):157-166. doi: 10.1017/ice.2023.170. Epub 2023 Aug 18.
3
Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric.医院流行病学家和感染预防专家对医院获得性菌血症和真菌血症作为一种潜在的医疗保健相关感染指标的看法。
Infect Control Hosp Epidemiol. 2019 May;40(5):536-540. doi: 10.1017/ice.2019.40. Epub 2019 Apr 1.
4
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.美国医院获得性菌血症和真菌血症的评估作为一种潜在的医疗保健质量衡量标准：一项横断面研究。
BMJ Qual Saf. 2024 Jul 22;33(8):487-498. doi: 10.1136/bmjqs-2023-016831.
5
RE: Preventability of hospital onset bacterermia and fungemia: A pilot study of potential healthcare-associated infection outcome measure, by Dantes et al (2019).主题：医院获得性菌血症和真菌血症的可预防性：Dantes等人（2019年）对潜在医疗相关感染结局指标的一项初步研究
Infect Control Hosp Epidemiol. 2019 Oct;40(10):1209-1210. doi: 10.1017/ice.2019.193. Epub 2019 Jul 25.
6
Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia.制定和评估结构化指南以评估医院获得性菌血症和真菌血症的可预防程度。
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1326-1332. doi: 10.1017/ice.2021.528. Epub 2022 Jan 28.
7
Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.预防血管通路装置相关的医院获得性菌血症和真菌血症：新兴观点综述与技术层面综合分析
Clin Infect Dis. 2025 Feb 24;80(2):444-450. doi: 10.1093/cid/ciae245.
8
Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.与美国医院中心静脉相关血流感染和医院获得性菌血症及真菌血症相关的特征、成本和结局。
Infect Control Hosp Epidemiol. 2023 Dec;44(12):1920-1926. doi: 10.1017/ice.2023.132. Epub 2023 Jul 10.
9
Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections.导管相关尿路感染（CAUTI）和非 CAUTI 医院获得性尿路感染：相对负担、成本、结局以及相关的医院获得性菌血症和真菌血症感染。
Infect Control Hosp Epidemiol. 2024 Jul;45(7):864-871. doi: 10.1017/ice.2024.26. Epub 2024 Feb 20.
10
Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.医院获得性菌血症和真菌血症：比较 267 家医院的两种风险调整模型的预测因素和基准比较可行性评估。
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1317-1325. doi: 10.1017/ice.2022.211. Epub 2022 Sep 9.
引用本文的文献
1
Integrating Nonindividual Patient Features in Machine Learning Models of Hospital-Onset Bacteremia.将非个体患者特征整合到医院获得性菌血症的机器学习模型中。
JAMA Netw Open. 2025 Jul 1;8(7):e2518815. doi: 10.1001/jamanetworkopen.2025.18815.
2
Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals, 2018 to 2022.医院获得性菌血症和真菌血症作为一种新型自动监测指标：来自四家欧洲大学医院的结果，2018年至2022年
Euro Surveill. 2025 Jun;30(24). doi: 10.2807/1560-7917.ES.2025.30.24.2400613.
3
Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study.医院获得性菌血症和真菌血症的自动监测：一项荷兰多中心研究的可行性及流行病学结果
Infect Control Hosp Epidemiol. 2025 Feb 26;46(5):1-9. doi: 10.1017/ice.2025.29.
4
Hospital-onset bacteremia in the neonatal intensive care unit: strategies for risk adjustment.新生儿重症监护病房的医院获得性菌血症：风险调整策略
Infect Control Hosp Epidemiol. 2025 Feb 17;46(4):1-7. doi: 10.1017/ice.2024.238.
5
Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.美国医院获得性菌血症和真菌血症的评估作为一种潜在的医疗保健质量衡量标准：一项横断面研究。
BMJ Qual Saf. 2024 Jul 22;33(8):487-498. doi: 10.1136/bmjqs-2023-016831.
6
Strengthening hospital epidemiology & infection prevention research capacity in India to curb antimicrobial resistance.加强印度医院流行病学与感染预防研究能力以遏制抗菌药物耐药性。
Indian J Med Res. 2024 Jan 1;159(1):7-9. doi: 10.4103/ijmr.ijmr_1919_23. Epub 2024 Mar 4.
7
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics.诊断管理以改善患者结局和医疗保健相关感染 (HAI) 指标。
Infect Control Hosp Epidemiol. 2024 Apr;45(4):405-411. doi: 10.1017/ice.2023.284. Epub 2024 Jan 11.
8
Healthcare-associated infections and conditions in the era of digital measurement.数字测量时代的医疗保健相关感染和状况。
Infect Control Hosp Epidemiol. 2024 Jan;45(1):3-8. doi: 10.1017/ice.2023.139. Epub 2023 Sep 25.
9
Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.印度 2 家医院的医院获得性菌血症和真菌血症的流行病学和可预防措施。
Infect Control Hosp Epidemiol. 2024 Feb;45(2):157-166. doi: 10.1017/ice.2023.170. Epub 2023 Aug 18.
10
Prevalence of Hospital-Onset Bacteremia Pre- and Post-Implementation of a Needleless Blood Sampling Device From Existing Peripheral Catheters.现有外周导管预实施和实施无针采血器前后医院获得性菌血症的患病率。
J Infus Nurs. 2023;46(6):332-337. doi: 10.1097/NAN.0000000000000513. Epub 2023 Jul 24.
本文引用的文献
1
Culture if spikes? Indications and yield of blood cultures in hospitalized medical patients.血培养阳性？住院内科患者血培养的指征及阳性率
J Hosp Med. 2016 May;11(5):336-40. doi: 10.1002/jhm.2541. Epub 2016 Jan 13.
2
A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?一项关于医院获得性菌血症的多中心纵向研究：是时候采用新的质量结果指标了吗？
Infect Control Hosp Epidemiol. 2016 Feb;37(2):143-8. doi: 10.1017/ice.2015.261. Epub 2015 Oct 23.
3
Comparison of total hospital-acquired bloodstream infections to central line-associated bloodstream infections and implications for outcome measures in infection control.比较医院获得性血流感染与中心静脉相关血流感染的差异，以及其对感染控制中结局指标的影响。
Infect Control Hosp Epidemiol. 2013 Sep;34(9):984-6. doi: 10.1086/671730. Epub 2013 Jul 25.
4
Clinical and economic impact of contaminated blood cultures within the hospital setting.医院环境中污染血培养的临床和经济影响。
J Hosp Infect. 2011 Mar;77(3):233-6. doi: 10.1016/j.jhin.2010.09.033. Epub 2011 Jan 7.
5
Guidelines on blood cultures.血培养指南。
J Microbiol Immunol Infect. 2010 Aug;43(4):347-9. doi: 10.1016/S1684-1182(10)60054-0.
6
An intervention to decrease catheter-related bloodstream infections in the ICU.一项降低重症监护病房导管相关血流感染的干预措施。
N Engl J Med. 2006 Dec 28;355(26):2725-32. doi: 10.1056/NEJMoa061115.
7
Financial and clinical impact of false-positive blood culture results.血培养假阳性结果的财务和临床影响。
Clin Infect Dis. 2001 Aug 1;33(3):296-9. doi: 10.1086/321881. Epub 2001 Jun 21.
8
Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.黏膜屏障损伤：血液系统恶性肿瘤强化治疗的生物学、病理学、临床对应情况及后果：综述
Bone Marrow Transplant. 2000 Jun;25(12):1269-78. doi: 10.1038/sj.bmt.1702447.
Zotero 插件